patient ventilator News
-
Lungpacer Medical, Inc. Announces FDA Approval of Emergency Use Authorization of the Lungpacer Diaphragm Pacing Therapy System to Help Address COVID-19 Pandemic
Lungpacer Medical, Inc., a medical device company developing an intravenous catheter-based phrenic-nerve-pacing system, announced today that the FDA has approved the Emergency Use Authorization for the use of the Lungpacer Diaphragm Pacing Therapy System (DPTS) to assist in weaning patients determined by their healthcare provider to be at high risk of weaning failure. According to the FDA ...
-
VentFree Respiratory Muscle Stimulator receives FDA Emergency Use Authorization for Use During COVID-19 Pandemic
Liberate Medical today announced that it has received Federal Drug Administration (FDA) Emergency Use Authorization for its VentFree™ Respiratory Muscle Stimulator, intended to be used to reduce disuse atrophy of the abdominal wall muscles, which may reduce the number of days adult patients require mechanical ventilation, including those patients with COVID-19. Reducing the time patients ...
-
Liberate Medical Announces CE Marking for its VentFree Respiratory Muscle Stimulator
Liberate Medical, a medical device company developing novel non-invasive electrical muscle stimulation devices to help patients with pulmonary conditions, today announced that it has received CE marking for its VentFree™ Respiratory Muscle Stimulator and ISO 13485 certification for its quality management system. The VentFree stimulator applies proprietary non-invasive electrical ...
-
New Support for Covid ICU Patients Now Available in the USA
USA. Ergotrics is pleased to present the world’s first inflatable prone ventilation support to improve prone ventilation in the Intensive Care Unit (ICU). Scientific studies highlight the benefits of optimized PEEP and long recruitment for ARDS patients ventilated in alternating supine/prone position, but it is one of the most challenging and ergonomically demanding position changes for ...
By Ergotrics NV
-
Liberate Medical Presents Data from its Pilot Trial of VentFree, a Muscle Stimulator for Mechanically Ventilated Patients, at the American Thoracic Society 2019 International Conference
Liberate Medical, a clinical-stage medical device company, developing novel electrical muscle stimulation devices that non-invasively address pulmonary conditions, today announced the results from its recently completed pilot trial of the VentFree Muscle Stimulator during an oral presentation at the American Thoracic Society International Conference (“ATS”) in Dallas, TX. ...
-
Synaptive Medical Establishes Partnership with O-Two Medical Technologies, Inc., to Manufacture Ventilators for COVID-19 Patients
Synaptive Medical, a leader in robotic surgical and imaging technologies, announced today the company has established a partnership with O-Two Medical Technologies, Inc., a world leader in controlled ventilation, for the production of O-Two’s e700 portable transport ventilator for patients impacted worldwide by COVID-19. As part of the agreement, Synaptive will leverage its expertise in ...
-
Liberate Medical Reports Positive Pilot Trial Results of VentFree Respiratory Muscle Stimulator
Applying non-invasive electrical stimulation to the expiratory abdominal muscles may reduce abdominal muscle atrophy and markedly reduce the number of days adult patients require mechanical ventilation – a potentially important finding for weaning ventilated patients, including seriously ill COVID-19 patients, and improving patient outcomes. Liberate Medical today announced the results of ...
-
Health Canada Grants Emergency Use Authorization for N8 Medical CeraShield™ Endotracheal Tubes in Mechanically Ventilated COVID-19 Patients
N8 Medical, LLC (N8 Medical) today announced that Health Canada has granted Dr. John Muscedere of Kingston General Hospital’s emergency request to begin using the N8 Medical CeraShield™ Endotracheal Tubes in mechanically-ventilated COVID-19 patients. N8 Medical’s CeraShield™ Endotracheal Tube has a patented anti-fouling coating that is designed to prevent deadly bacterial ...
-
Lungpacer Medical Accelerates Pivotal Clinical Study with AeroPace™ System
Lungpacer Medical, a leading medical device innovation company, today announced the introduction of the AeroPace™ System, a next generation product, into the RESCUE 3 pivotal clinical study studying faster ventilator independence. Lungpacer is dedicated to natural breathing by developing minimally invasive technologies designed to help patients wean off mechanical ventilation and breathe on ...
-
Liberate Medical’s VentFree Muscle Stimulator Receives Breakthrough Device Designation from the FDA to Reduce Mechanical Ventilation Duration
Liberate Medical, a clinical stage medical device company, focused on the development of novel non-invasive neuromuscular electrical stimulation devices to address pulmonary conditions, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the company’s VentFree muscle stimulator. The proposed indication for the device is preventing ...
-
N8 Medical Announces its CeraShield™ Coating inhibits COVID-19 Virus Growth on Endotracheal Tubes
N8 Medical, LLC, a privately held biotechnology company, today announced that its CeraShield™ coated endotracheal tubes significantly reduced the growth of COVID-19 virus in recent testing. The testing shows statistically significant reduction in the growth of the COVID-19 virus on the tube surface in 60 minutes. Ordinary uncoated endotracheal tubes either allowed increased virus growth or ...
-
E0467 “Same or Similar” Restrictions Eliminated by Centers for Medicare and Medicaid Services
Bothell, Washington - On May 29, 2020, the Centers for Medicare and Medicaid Services (CMS) updated its policy for HCPCS code E0467 (Multi-Function Ventilator) removing “same or similar” restrictions and paving the way for increased access to integrated respiratory care for ventilator users regardless of their device billing history. Previously, same or similar restrictions ...
-
CONVERT Clinical Trial Data Presented at ERS Demonstrates Early Success of AeriSeal System in Patients with Advanced COPD/Emphysema
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, announces the presentation of interim results from the CONVERT Study at the 2022 European Respiratory Society (ERS) International Conference. Data on the first 40 patients in the study demonstrated that treatment with the AeriSeal System successfully converted the ...
-
Backed by $18 Million and a Nationwide Agreement With One of the Largest Private Hospital Networks in The U.S., ENvizion® Unveils Enteral Feeding Tube ‘GPS’ Tech
ENvizion®, the FDA 510(k) cleared leader in enteral feeding placement navigation technology, announces its agreement with one of the largest private hospital networks in the U.S., with more than one hundred hospitals, to provide ENvizion’s feeding tube placement navigation devices nationwide. The company’s endeavor is backed by $18 million in investment. Key investors include ...
-
IONICON PTR-TOF instruments deployed for COVID-19 detection in breath
There is a high probability that this disease can be detected in the exhaled breath but also monitoring the impact of treatment or medication is highly relevant. Sampling exhaled breath is non-invasive and simple. But the analysis is the challenge: Several hundred volatile compounds have so far been identified in exhaled breath and their range of concentrations, typically in the ...
-
IONICON Analyzers at the Forefront of International COVID-19 Testing Research
A non-invasive test for COVID-19 with instant results would be a gamechanger in the efforts against COVID-19. Breath analysis shows a great potential for a rapid, non-invasive detection of COVID-19 infections. Follow our journey around the world, where we shine a light on current research projects where IONICON PTR-TOF instruments are deployed fighting this global pandemic by testing breath for ...
-
Merck announces recipients of `will to win` scholarship for students with Asthma
Merck today announced recipients of the 2010 Will to Win Scholarship, which recognizes high school seniors with asthma who are pursuing higher education. Ten scholarships of $5,000 each have been awarded to two high school seniors who demonstrated outstanding performance in each of the five scholarship categories: performing arts, visual arts, community service, athletics and science. "The 2010 ...
-
Fighting COVID-19 ! We are together
Fighting the epidemic together – Yaguo and the Shanghai Tianyi Group donated 8-million-yuan worth of innovative respiratory equipment to help Hubei’s new coronavirus pneumonia epidemic. On February 18th 2020, Beijing Yaguo Technology Co., Ltd. (“Yaguo”) and the Shanghai Tianyi Industry Holding Group Co., Ltd. (“Tianyi”) jointly donated medical equipment with a ...
-
FDA Grants ALung Emergency Use Authorization (EUA) to the ALung for the Treatment of COVID-19
PITTSBURGH – (BUSINESS WIRE) – April 24, 2020 – ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced that the Food and Drug Administration (FDA) has granted the Company Emergency Use Authorization (EUA) designation to the Hemolung® Respiratory ...
-
Ionicon PTR-TOF instruments deployed for COVID-19 detection in breath
SARS-CoV-2 currently has the world in its grasp. A quick, non-invasive test to identify an infection would be a tremendous step forward. There is a high probability that this disease can be detected in the exhaled breath but also monitoring the impact of treatment or medication in exhaled breath is highly relevant. IONICON PTR-TOF systems have become the de-facto standard for real-time breath ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you